AKT1 and breast carcinoma: KEGG pathway enrichment results indicated that THSWD might exert its therapeutic effects on breast cancer by regulating Ras, FoxO, and PI3K-Akt signaling pathways, which have been confirmed to be involved in breast carcinogenesis.